Transarterial chemoembolization (TACE ... carcinoma found that 86.6% of study participants had a complete response to treatment. The 3-year survival rate after TACE was 75.4%.

Often diagnosed at advanced stages, the therapeutic landscape is limited, with transarterial chemoembolization ... ICD and enhancing adaptive immune responses while minimizing immunosuppressive ...